23 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
to retain and motivate these key personnel on acceptable terms. We also experience competition for the hiring of scientific and clinical personnel from
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
to retain and motivate these key personnel on acceptable terms. We also experience competition for the hiring of scientific and clinical personnel from
6-K
EX-99.2
XRTX
XORTX Therapeutics Inc
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
of individual and corporate performance and the anticipated future hiring requirements of the Company. Also, the Compensation Committee considers the overall … three formal meetings and several informal meetings to address compensation matters including matters relating to hiring decisions and option awards
6-K
EX-99.3
d4uk8
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
l2r85 faogcy64xn
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
oxvuy
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
d9670xy3o9 eh24qg
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
mbe9a9zm ns
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
ymqpnj kjescj
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
jw512y3a6 321
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
wzzj50zo
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
sfcp4qc ek
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
7fsqewx
29 Nov 21
Condensed Interim Consolidated Financial Statements
12:00am
424B4
f9mr1aqjes8oyi
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
hbart
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
snwb ivz868fmh
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
h1kjiwacdpj7je
11 Aug 21
Registration statement (foreign)
9:55pm